CN1136899C - Chinese medicine for treating mastoplasia - Google Patents

Chinese medicine for treating mastoplasia Download PDF

Info

Publication number
CN1136899C
CN1136899C CNB011253142A CN01125314A CN1136899C CN 1136899 C CN1136899 C CN 1136899C CN B011253142 A CNB011253142 A CN B011253142A CN 01125314 A CN01125314 A CN 01125314A CN 1136899 C CN1136899 C CN 1136899C
Authority
CN
China
Prior art keywords
radix
rhizoma
rhizoma chuanxiong
medicine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011253142A
Other languages
Chinese (zh)
Other versions
CN1334114A (en
Inventor
宋崇淑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011253142A priority Critical patent/CN1136899C/en
Publication of CN1334114A publication Critical patent/CN1334114A/en
Application granted granted Critical
Publication of CN1136899C publication Critical patent/CN1136899C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a traditional Chinese medicine formula for treating hyperplasia of mammary glands, which is mainly prepared from hemlock parsley, cassia twig, asarum herb, dahurian angelica, rhizoma pleionis, Fritillariae Thunbergii Bulbus, selfheal spike, herba agastachis, angelica, oyster and seaweed. Simultaneously, other medicinal materials can be added to the formula according to different symptoms. The formula has the advantages that the purposes of improving the metabolism of human bodies and eliminating stasis accumulation in vivo are achieved by supplementing and nourishing qi and blood, softening and resolving hard mass, and activating blood circulation to dissipate blood stasis; pain caused by hyperplasia of mammary glands can be relieved by regulating qi for relieving pain; Chinese herbal medicines are used as raw materials, so that toxic and side effects can be avoided; the effective rate is 93% according to clinical tests of more than 1000 examples; a medicine prepared by the formula is convenient to take and has the advantage of low cost. Thereby, the formula is suitable for common people.

Description

A kind of medicine for the treatment of cyclomastopathy
(1) technical field: the present invention relates to medicine, further is the medicine that is used for the treatment of cyclomastopathy, is particularly useful for treating the Chinese Traditional Medicines of cyclomastopathy.
(2) background technology: cyclomastopathy refers to the block not of uniform size of generation in the breast, belonging to the non-inflammation mastopathy, is modal breast disease among the women, accounts for whole mastotic 2/3rds, the medicine of multiple treatment cyclomastopathy is arranged in the market, and effect has nothing in common with each other.Recently " the breast peace sheet " sold on the market adopts 10 kinds of traditional Chinese medicines such as the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Radix Asparagi, the Radix Astragali, Radix Bupleuri, Olibanum, Herba Epimedii, Endothelium Corneum Gigeriae Galli to make, and the concrete quantity of each medical material is not quite clear.
(3) summary of the invention: the objective of the invention is to be to provide a kind of Chinese patent medicine formula for the treatment of cyclomastopathy, the medicine that adopts this method to produce, result of use is good.
The objective of the invention is to realize: a kind of medicine for the treatment of cyclomastopathy by following scheme, mainly by Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, compatibility forms, more than each medical material, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.5~1.5,0.5~1.5,0.5~1.5,0.5~1.5,1~3,1~3,1~3,1~3,7~9,7~9.
Among the present invention, Concha Ostreae can replace with Concha Meretricis Seu Cyclinae or Concha Arcae, and Sargassum can replace with Thallus Laminariae (Thallus Eckloniae), and Herba Pogostemonis can replace with Herba Eupatorii.For taking different prescriptions at the different state of an illness, thereby heighten the effect of a treatment, the present invention also can add other related drugs, as Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan, Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi, Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi etc.
In this prescription, the effect that Concha Ostreae, Sargassum, Pseudobulbus Cremastrae Seu Pleiones have softening the hard mass, eliminating stagnation, regulate the flow of vital energy; Herba Pogostemonis, Bulbus Fritillariae Thunbergii have regulate the flow of vital energy, the effect of pain relieving, damp eliminating; Rhizoma Chuanxiong has the effect of promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling; Herba Asari, the Radix Angelicae Dahuricae have cold expelling, damp eliminating, analgesic effect; Spica Prunellae has the effect of heat-clearing and toxic substances removing.
" you are glad for the breast " capsule that adopts method provided by the invention to make has the following advantages: 1, by invigorating QI and blood, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, improve the human body metabolism thereby reach, eliminate the long-pending purpose of the stasis of blood in the body.2, regulating QI to relieve pain can be alleviated the pain that cyclomastopathy causes.3, adopting Chinese herbal medicine is raw material, has no side effect.4, by 1000 many cases clinical trials, effective percentage is 93%.5, taking convenience, cost are lower, are applicable to ordinary people.
(4) specific embodiment:, the present invention is done further narration below in conjunction with embodiment.
Embodiment 1: selecting Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, is 1 with Rhizoma Chuanxiong weight, and all the other each medical materials are followed successively by: 0.5,0.5,0.5,0.5,1,1,1,1,7,7.
During making, screen successively, operation such as rinsing, oven dry, pulverizing, dress capsule, make capsule, also can be made into tablet or pill.
Embodiment 2: selecting Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, is 1 with Rhizoma Chuanxiong weight, and all the other each medical materials are followed successively by: 1.5,1.5,1.5,1.5,3,3,3,3,9,9.
Manufacture method is with embodiment 1.
Embodiment 3: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Meretricis Seu Cyclinae, Thallus Laminariae (Thallus Eckloniae), also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.7,0.7,0.7,0.7,1.3,1.3,1.3,1.3,7.4,7.4,1.4,0.6,0.9,1.4,2.4,0.9.
Manufacture method is with embodiment 1.
Embodiment 4: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Meretricis Seu Cyclinae, Thallus Laminariae (Thallus Eckloniae), also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.3,1.3,1.3,1.3,2.7,2.7,2.7,2.7,8.4,8.4,2.6,1.8,2.1,2.6,3.6,2.1.
Manufacture method is with embodiment 1.
Embodiment 5: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.8,0.8,0.8,0.8,1.4,1.4,1.4,1.4,7.1,7.1,1.7,0.8,1.2,1.7,2.7,1.2.
Manufacture method is with embodiment 1.
Embodiment 6: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.2,1.2,1.2,1.2,2.4,2.4,2.4,2.4,8.1,8.1,2.3,1.6,1.8,2.3,3.3,1.8.
Manufacture method is with embodiment 1.
Embodiment 7: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.8,0.8,0.8,0.8,1.4,1.4,1.4,1.4,7.1,7.1,0.9,0.5,0.5,1.4,0.4,0.6,0.9,0.2.
Manufacture method is with embodiment 1.
Embodiment 8: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.2,1.2,1.2,1.2,2.4,2.4,2.4,2.4,8.1,8.1,2.1,1.5,1.5,2.6,1.5,1.8,2.1,0.9.
Manufacture method is with embodiment 1.
Embodiment 9: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.8,0.8,0.8,0.8,1.4,1.4,1.4,1.4,7.1,7.1,1.1,0.7,0.7,1.6,0.6,0.8,1.1,0.4.
Manufacture method is with embodiment 1.
Embodiment 10: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.2,1.2,1.2,1.2,2.4,2.4,2.4,2.4,8.1,8.1,1.9,1.3,1.3,2.4,1.3,1.6,1.9,0.7.
Manufacture method is with embodiment 1.
Embodiment 11: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.9,0.9,0.9,0.9,1.6,1.6,1.6,1.6,7.3,7.3,0.9,2.4,1.4,0.2.
Manufacture method is with embodiment 1.
Embodiment 12: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.1,1.1,1.1,1.1,2.2,2.2,2.2,2.2,7.8,7.8,2.1,3.6,2.6,0.9.
Manufacture method is with embodiment 1.
Embodiment 13: select Rhizoma Chuanxiong 0.9g, Ramulus Cinnamomi 0.9g, Herba Asari 0.9g, Radix Angelicae Dahuricae 0.9g, Pseudobulbus Cremastrae Seu Pleiones 0.9g, Bulbus Fritillariae Thunbergii 1.7g, Spica Prunellae 1.7g, Herba Pogostemonis 1.7g, Radix Angelicae Sinensis 1.7g, Concha Ostreae 7.4g, Sargassum 7.4g, also comprise Radix Codonopsis 1.1g, Radix Astragali 2.6g, Rhizoma Atractylodis Macrocephalae 1.6g, Cortex Cinnamomi 0.4g in addition, screen successively, operation such as rinsing, oven dry, pulverizing, dress capsule, making heavily is the individual capsule of 0.5g/, also can be made into tablet or pill.
Embodiment 14: select Rhizoma Chuanxiong 1.1g, Ramulus Cinnamomi 1.1g, Herba Asari 1.1g, Radix Angelicae Dahuricae 1.1g, Pseudobulbus Cremastrae Seu Pleiones 1.1g, Bulbus Fritillariae Thunbergii 2.1g, Spica Prunellae 2.1g, Herba Pogostemonis 2.1g, Radix Angelicae Sinensis 2.1g, Concha Ostreae 7.7g, Sargassum 7.7g, also comprise Radix Codonopsis 1.9g, Radix Astragali 3.4g, Rhizoma Atractylodis Macrocephalae 2.4g, Cortex Cinnamomi 0.7g in addition, screen successively, operation such as rinsing, oven dry, pulverizing, dress capsule, making heavily is the individual capsule of 0.5g/, also can be made into tablet or pill.
In the embodiments of the invention, Concha Ostreae can replace with Concha Meretricis Seu Cyclinae or Concha Arcae, and Sargassum can replace with Thallus Laminariae (Thallus Eckloniae), and Herba Pogostemonis can replace with Herba Eupatorii.

Claims (5)

1, a kind of medicine for the treatment of cyclomastopathy, mainly form by Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum compatibility, it is characterized in that: with Rhizoma Chuanxiong weight is 1, all the other each medical materials are followed successively by, and 0.7~1.3,0.7~1.3,0.7~1.3,0.7~1.3,1.3~2.7,1.3~2.7,1.3~2.7,1.3~2.7,7.4~8.4,7.4~8.4.
2, a kind of medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, in the medical material that is increased, with Rhizoma Chuanxiong weight is 1, and each medical material heavily is followed successively by: 1.4~2.6,0.6~1.8,0.9~2.1,1.4~2.6,2.4~3.6,0.9~2.1.
3, a kind of medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and each medical material heavily is followed successively by: 0.9~2.1,0.5~1.5,0.5~1.5,1.4~2.6,0.4~1.5,0.6~1.8,0.9~2.1,0.2~0.9.
4, a kind of medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: also comprise Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi in addition, in the medical material that is increased, be 1 with Rhizoma Chuanxiong weight, each medical material heavily is followed successively by: 0.9~2.1,2.4~3.6,1.4~2.6,0.2~0.9.
5, according to claim 1 or 2 or 3 or 4 described a kind of medicines for the treatment of cyclomastopathy, it is characterized in that: Concha Ostreae replaces with Concha Meretricis Seu Cyclinae, and Sargassum replaces with Thallus Laminariae (Thallus Eckloniae), and Herba Pogostemonis replaces with Herba Eupatorii.
CNB011253142A 2001-08-09 2001-08-09 Chinese medicine for treating mastoplasia Expired - Fee Related CN1136899C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011253142A CN1136899C (en) 2001-08-09 2001-08-09 Chinese medicine for treating mastoplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011253142A CN1136899C (en) 2001-08-09 2001-08-09 Chinese medicine for treating mastoplasia

Publications (2)

Publication Number Publication Date
CN1334114A CN1334114A (en) 2002-02-06
CN1136899C true CN1136899C (en) 2004-02-04

Family

ID=4665952

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011253142A Expired - Fee Related CN1136899C (en) 2001-08-09 2001-08-09 Chinese medicine for treating mastoplasia

Country Status (1)

Country Link
CN (1) CN1136899C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103536765A (en) * 2013-10-24 2014-01-29 河南中医学院 Traditional Chinese medicament for treating mammary gland hyperplasia in lactation period
CN103920100B (en) * 2014-05-09 2016-09-28 马金风 A kind of pharmaceutical composition treating cyclomastopathy
CN104998192A (en) * 2015-07-13 2015-10-28 成都市飞龙水处理技术研究所青白江第一分所 Internal drug for treating benign hyperplasia of mammary glands and preparation method thereof
CN109331129A (en) * 2018-12-10 2019-02-15 陕西太白山天然植物开发有限公司 A kind of Chinese medicine dietary product and preparation method thereof suitable for the proliferation of mammary gland

Also Published As

Publication number Publication date
CN1334114A (en) 2002-02-06

Similar Documents

Publication Publication Date Title
CN1132643A (en) Medicine for diseases of liver and gall
CN100342891C (en) Medicine composition for hypertension and its preparation thereof
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN1130219C (en) Litholysizing bear gall powder
CN1269506C (en) Prepared Chinese traditional medicine for alopecia
CN1539441A (en) Compounded medicine for anti pathogeny and immunoenhancement
CN1201691A (en) Medicine for curing encephalatrophy and preparation thereof
CN1698735A (en) Medicine for treating psoriasis
CN1136899C (en) Chinese medicine for treating mastoplasia
CN1172672A (en) Chinese medicinal herb composition for treating cancer
CN1772100A (en) Medicine for treating psoriasis and its prepn
CN1943764A (en) The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer
CN1190218C (en) Chinese medicine for treating hyperosteogeny
CN1051471C (en) Drug composition for curing osteoporosis
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN1883642A (en) Medicine for treating mammary glands hyperplasia
CN100340284C (en) Jindan gallbladder stone dissolving capsule
CN1223886A (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN1105569C (en) Medicinal composition for stasis of blood
CN1186044C (en) Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1226045C (en) Medicine for treating headache
CN1319586C (en) Medicinal composition for treating brain apoplexy
CN1060076C (en) Gucixiao pill for removing spur
CN102225132A (en) Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee